Home › Therapeutic areas › Neurology › Charcot-Marie-Tooth Disease Type 2S
Charcot-Marie-Tooth Disease Type 2S (1 companies)
Companies with an active program in Charcot-Marie-Tooth Disease Type 2S.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| VNDA | Vanda Pharmaceuticals | CardiovascularDermatology+6 Rare | 1 | Approved | $231M | 27 |
No companies match.